Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00222352 · ClinicalTrials.gov registry record
Diagnosis and Treatment of ACS in the ED: The Impact of Rapid Bedside cTnI Testing on Outcomes
A clinical trial, sponsored by University of Cincinnati.
- Completed
- Registry status
- 2,000
- Enrollment target
NCT00222352 is a clinical trial that has completed, run by University of Cincinnati. The registered enrollment target is 2,000 participants.
The verdict
NCT00222352 has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- 2,000 participants
- Enrollment target
Study Summary
In a randomized, controlled clinical trial, point-of care testing at the bedside using the cardiac biomarker troponin I in ED patients with possible ACS will be compared to traditional testing of this assay for myocardial necrosis obtained in the central laboratory. Our hypothesis: point-of-care testing for troponin I will decrease the time for disposition of patients with possible ACS in the emergency setting and decrease the time required for administering appropriate therapies for these patients.
Interventions
- DIAGNOSTIC_TEST Point of Care cTnL testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2004-12 |
| Est. Completion | 2007-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00222352
The ClinicalTrials.gov registry entry for NCT00222352 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Point of Care cTnL testing is the first listed.
NCT00222352 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00222352 about?
NCT00222352 is a clinical study titled "Diagnosis and Treatment of ACS in the ED: The Impact of Rapid Bedside cTnI Testing on Outcomes". In a randomized, controlled clinical trial, point-of care testing at the bedside using the cardiac biomarker troponin I in ED patients with possible ACS will be compared to traditional testing of this assay for myocardial necrosis obtained in the central laboratory. Our hypothesis: point-of-care tes...
What is the current status of trial NCT00222352?
This trial is currently completed. The enrollment target is 2,000 participants. The study started on 2004-12. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00222352?
The interventions under investigation include: Point of Care cTnL testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT00222352?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.